Introduction to the blog
Why Research on mRNA Vaccine Worth a Nobel Prize: We’ve seen that, recently the Nobel Prize Winner List 2023 was released. Also, in the subject of Physiology and Medicine (One of the Subjects and subjects on Nobel Prizes Distributed) Katalin Karikó and Drew Weissman won the Nobel Prize 2023.
But, the thing we need to put into our consideration is that, they have won the Nobel Prize on Physiology and Medicine 2023 for their research on the mRNA vaccine which helped Humankind to fight the deadly COVID-19 Virus & its multiple variants.
Is it worth giving the Nobel Prize to them? Was then really needed? We’ll discuss it in this blog and also provide you a broad understanding of why the Nobel Prize on Physiology and Medicine 2023 was given to Katalin Karikó and Drew Weissman & why it was needed.
So, let’s start-
What is Nobel Prize in Physiology and Medicine?
The Nobel Prize in Physiology or Medicine is one of the Nobel Prizes established by the will of Alfred Nobel in 1895. It is awarded annually by the Royal Swedish Academy of Sciences to scientists who have made significant contributions to the field of medical science or physiology.
The prize recognizes outstanding discoveries that have advanced our understanding of life processes and improved human health. The laureates receive a medal, a diploma, and a monetary award.
Who is Katalin Karikó?
Katalin Karikó, also known as Kati Kariko, was born on January 17, 1955, in Szolnok, Hungary. She holds dual citizenship in Hungary and the United States.
Karikó is a highly acclaimed biochemist known for her pioneering work in mRNA technology, particularly its applications in immunology and therapies.
Karikó pursued her education at the University of Szeged, earning her Bachelor of Science (BSc) degree in biology in 1978 and her Ph.D. in biochemistry in 1982.
She initially worked as a researcher at the University of Szeged and later moved to the United States to join Temple University. Over the course of her scientific career, Karikó spent more than two decades as a researcher at the University of Pennsylvania, where she faced numerous challenges, including demotion and lack of support.
Despite the obstacles, Karikó's determination and groundbreaking research on mRNA technologies led to the development of effective mRNA vaccines, which played a crucial role in the global fight against COVID-19.
For her significant contributions to science and medicine, Karikó received the prestigious Nobel Prize in Physiology or Medicine in 2023, among several other awards.
Her scientific career spans institutions such as the University of Szeged, Temple University, the University of Pennsylvania, and BioNTech.
Who is Drew Weissman?
Drew Weissman is an American physician, immunologist, and prominent figure in RNA biology. Born on September 7, 1959, in Lexington, Massachusetts, Weissman has made significant contributions to the development of mRNA vaccines, most notably those for COVID-19 produced by BioNTech/Pfizer and Moderna.
He holds the position of Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania.
Weissman's work, in collaboration with biochemist Katalin Karikó, has been pivotal in developing effective mRNA vaccines against COVID-19. Their groundbreaking research concerning nucleoside base modifications in mRNA earned them the prestigious Nobel Prize in Physiology or Medicine in 2023.
In addition to the Nobel Prize, Weissman has received several other awards, including the Lasker–DeBakey Clinical Medical Research Award, and was elected to the National Academy of Medicine and the American Academy of Arts and Sciences in 2022.
Weissman's journey in science began with his B.A. and M.A. degrees from Brandeis University, where he majored in biochemistry and enzymology.
He then went on to complete his M.D. and Ph.D. at Boston University, followed by residency and fellowship programs. His work continues to shape the field of immunology and the development of life-saving vaccines.
About mRNA Vaccine & its importance
mRNA vaccines represent a groundbreaking development in the fight against COVID-19. Unlike traditional vaccines that use live, attenuated, or inactivated viruses or bacteria, mRNA vaccines introduce a piece of genetic material that corresponds to a viral protein, usually the spike protein found on the virus's membrane.
This triggers the immune system to produce antibodies without exposing individuals to the virus itself. Katalin Karikó and Drew Weissman's work on nucleoside base modifications enabled the development of effective mRNA vaccines.
They addressed challenges such as mRNA's fragility by encapsulating it in a layer of oily lipids, creating lipid nanoparticles that protect the mRNA from degradation and mimic how a virus presents itself to the body.
Advantages of mRNA Vaccines
A significant advantage of mRNA vaccines is their adaptability. Because they only require the genetic code, they can be quickly updated to address emerging variants of a virus. This flexibility proved essential during the COVID-19 pandemic, allowing for the rapid development of vaccines by companies like Moderna and Pfizer/BioNTech.
What would have happened if there were no mRNA Vaccine?
If there were no mRNA vaccines, the global response to COVID-19 would have been significantly impacted. Traditional vaccine development methods generally take longer, so the availability of effective vaccines would have been delayed.
This could have resulted in more widespread infection, increased mortality rates, and prolonged economic and social disruptions.
The absence of mRNA vaccines would also have limited the ability to quickly adapt to emerging variants of the virus, potentially prolonging the pandemic and increasing the challenge of achieving widespread immunity.
How mRNA Vaccine Fought to COVID-19 Virus?
mRNA vaccines played a crucial role in the fight against the COVID-19 virus by leveraging a novel approach to vaccine development. Unlike traditional vaccines, mRNA vaccines do not use live, attenuated, or inactivated viruses.
Instead, they introduce a piece of genetic material, specifically messenger RNA (mRNA), that corresponds to a viral protein, typically the spike protein found on the virus's membrane.
Upon administration, the mRNA enters the cells of the recipient, instructing them to produce the viral protein.
This triggers the immune system to recognize the protein as foreign, initiating an immune response that includes the production of antibodies.
If the individual is later exposed to the actual virus, the immune system is primed to recognize and fight it effectively.
Why is mRNA Vaccine Better Than traditional Vaccines for COVID-19
mRNA vaccines have several advantages over traditional vaccines for COVID-19. We have listed a few of them below:
1. Speed of Development: mRNA vaccines can be developed faster than traditional vaccines because they are based on the genetic code of the virus, which can be quickly synthesized.
2. Adaptability: mRNA vaccines can be easily updated to address new variants of the virus, making them more flexible in responding to an evolving pandemic.
3. Safety: mRNA vaccines do not use live virus, so there is no risk of causing disease in the vaccinated individual.
4. Strong Immune Response: mRNA vaccines have shown to induce a robust immune response, generating both antibodies and T-cell responses, which can provide more comprehensive protection.
5. Fewer Side Effects: mRNA vaccines have generally shown fewer side effects compared to traditional vaccines.
6. No Adjuvants Needed: mRNA vaccines do not require adjuvants, which are substances added to vaccines to enhance the immune response.
7. Cold Storage: mRNA vaccines can be stored at refrigerator temperatures for a certain period, making distribution easier than initially thought.
8. No Risk of Integration: mRNA vaccines do not integrate into the host genome, so there is no risk of genetic alterations.
9. Production Scalability: mRNA vaccines can be produced on a large scale using cell-free systems, which can be easier and faster than traditional vaccine production methods.
10. Potential for Future Applications: The technology used in mRNA vaccines could be applied to other diseases and conditions, opening up new possibilities for future vaccines and therapies.
Difference between mRNA vaccine and traditional vaccine - mRNA vaccine vs traditional vaccine COVID
We have listed the Key Differences between mRNA Vaccine and Traditional Vaccine Below:
Feature |
mRNA Vaccine |
Traditional Vaccine |
Development Speed |
Faster development based on genetic code |
Slower development using live, attenuated, or inactivated viruses |
Adaptability |
Easily updated for new variants |
More challenging to update for new variants |
Immune Response |
Robust immune response with both antibodies and T-cell responses |
Primarily antibody response; T-cell response may vary |
Safety |
No live virus used, reducing risk of disease |
Risk of disease varies depending on vaccine type |
Side Effects |
Generally fewer side effects |
Side effects may be more common |
Adjuvants |
No adjuvants needed |
Adjuvants may be required to enhance immune response |
Storage Requirements |
Initially required ultra-cold storage, but now can be stored at refrigerator temperatures for a period |
Generally easier storage conditions |
Genome Integration |
No risk of integration into the host genome |
No risk of integration into the host genome (for most traditional vaccines) |
Production Scalability |
Scalable production using cell-free systems |
Traditional production methods may be less scalable |
Future Applications |
Potential for applications to other diseases |
Limited to the diseases targeted by the vaccine |
Advantages and disadvantages of mRNA vaccines
Advantages of mRNA Vaccines
1. Rapid Development: mRNA vaccines can be developed faster than traditional vaccines because they rely on the genetic code of the virus.
2. Strong Immune Response: mRNA vaccines induce a robust immune response, generating both antibodies and T-cell responses, providing comprehensive protection.
3. Adaptability: mRNA vaccines can be easily updated to address new variants of a virus, making them more flexible in responding to an evolving pandemic.
4. Safety: mRNA vaccines do not use live virus, so there is no risk of causing disease in the vaccinated individual.
5. Broader Applications: The technology used in mRNA vaccines could be applied to other diseases and conditions, opening up new possibilities for future vaccines and therapies.
Disadvantages of mRNA Vaccines
1. Storage Requirements: mRNA vaccines initially required ultra-cold storage, although this has improved over time.
2. Limited History: mRNA vaccines have a shorter history compared to traditional vaccines, so long-term effects are still being studied.
3. Public Perception: Some people may have concerns or skepticism about the new technology used in mRNA vaccines.
4. Cost: The production and distribution of mRNA vaccines may be more expensive than traditional vaccines.
5. Immune Reaction: Although rare, mRNA vaccines may cause more side effects in certain individuals compared to traditional vaccines.
How do traditional vaccines work
Traditional vaccines work by introducing a weakened, inactivated, or partial form of a virus or bacteria to the body. This stimulates the immune system to recognize and mount a defense against the pathogen without causing the actual disease.
There are different types of traditional vaccines, such as inactivated vaccines, live attenuated vaccines, and subunit or recombinant vaccines, which use various parts of the pathogen.
By exposing the body to a harmless version of the pathogen, traditional vaccines help the immune system build memory and provide immunity against future infections with the actual virus or bacteria.
FAQ’s related to Nobel Prize on mRNA Research
Question-1:
What is the Nobel Prize?
Question-2:
What is the meaning of the Nobel Prize?
Question-3:
What are the categories of the Nobel Prize?
Question-4:
What are the subjects of the Nobel Prize?
Question-5:
What is the Nobel Peace Prize?
Question-6:
Who won the Nobel Prize in Physiology or Medicine in 2023?
Question-7:
Where can I find a list of All Nobel Prize winners?
Question-8:
Why is the mRNA vaccine more effective?
Question-9:
Why is the mRNA vaccine better?
Question-10:
Why was the mRNA vaccine developed?
Question-11:
What is Nobel Prize Winner List 2023?
Answer. The Nobel Prize Winner List for 2023 includes the following laureates across various categories:
1. Nobel Prize in Physics: Pierre Agostini, Ferenc Krausz, and Anne L’Huillier "for experimental methods that generate attosecond pulses of light for the study of electron dynamics in matter.”
2. Nobel Prize in Physiology or Medicine: Katalin Karikó and Drew Weissman "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.”
3. Nobel Prize in Chemistry: Moungi G. Bawendi, Louis E. Brus, and Alexei I. Ekimov "for the discovery and synthesis of quantum dots.”
4. Nobel Prize in Literature: Jon Fosse "for his innovative plays and prose which give voice to the unsayable.”
5. Nobel Peace Prize: Narges Mohammadi "for her fight against the oppression of women in Iran and her fight to promote human rights and freedom for all.”
6. The Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel 2023: Claudia Goldin "for having advanced our understanding of women’s labor market outcomes.”
Question-12:
Who won the 2023 Nobel Prize in Physiology or Medicine and for what discovery?
Question-13:
Who were the 2022 Nobel Prize winners in Physiology or Medicine and what was
their contribution?
Question-14:
Who received the Nobel Prize in Physiology or Medicine in 2021 and for what
research?
Question-15:
Which individuals won the Nobel Prize in Physiology or Medicine in 2020 and
what was the achievement?
Question-16:
Who were the winners of the 2019 Nobel Prize in Physiology or Medicine and for
what reason?
Question-17:
Which researchers received the Nobel Prize in Physiology or Medicine in 2018
and what was their contribution?
Question-18:
Who won the 2017 Nobel Prize in Physiology or Medicine and what was their
discovery?
Question-19:
Which scientists won the Nobel Prize in Physiology or Medicine in 2016 and for
what?
Question-20:
Who were the winners of the Nobel Prize in Physiology or Medicine in 2015 and
what was their contribution?
Question-21:
Who won the Nobel Prize in Physiology or Medicine in 2014 and for what?
Question-22:
Who were the recipients of the Nobel Prize in Physiology or Medicine in 2013
and what was their discovery?
Question-23:
Which scientists won the Nobel Prize in Physiology or Medicine in 2012 and for
what?
Question-24:
Who were the winners of the Nobel Prize in Physiology or Medicine in 2011 and
what was their discovery?
Question-25:
Who won the Nobel Prize in Physiology or Medicine in 2010 and for what?
Question-26:
Which researchers won the Nobel Prize in Physiology or Medicine in 1998 and for
what discovery?
Question-27:
Who were the winners of the Nobel Prize in Physiology or Medicine in 1995 and
what was their contribution?
Question-28:
Who won the Nobel Prize in Physiology or Medicine in 1991 and what was their
discovery?
Question-29:
Who were the winners of the Nobel Prize in Physiology or Medicine in 1976 and
what was their discovery?
Question-30:
Who won the Nobel Prize in Physiology or Medicine in 1974 and for what?
Question-31:
Which scientists won the Nobel Prize in Physiology or Medicine in 1973 and what
was their discovery?
Question-32:
Who were the winners of the Nobel Prize in Physiology or Medicine in 1972 and
what was their contribution?
Question-33:
Who won the Nobel Prize in Physiology or Medicine in 1970 and for what?
Question-34:
Who were the winners of the Nobel Prize in Physiology or Medicine in 1945 and
what was their discovery?
Answer. Sir Alexander Fleming, Ernst Boris Chain, and Sir Howard Walter Florey won the Nobel Prize in Physiology or Medicine in 1945 for the discovery of penicillin and its curative effect in various infectious diseases.
0 Comments